NAPLES, Fla.--(BUSINESS WIRE)--Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, ...
Catalyst and Eisai will work closely together to help ensure a seamless transition of certain key members of the FYCOMPA U.S. business unit to Catalyst, and to that end, the companies have negotiated ...
Catalyst OrthoScience Inc. (“Catalyst”), a private medical technology leader focused on shoulder arthroplasty, the fastest growing segment in the orthopedics market, announced today the full ...
CORAL GABLES, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), today reported financial results for the first quarter of 2025 and ...
Joby Aviation is positioned as a leading eVTOL manufacturer, pursuing vertical integration and in-house production to build a ...
CORAL GABLES, Fla., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals (CPRX), Inc. today reported financial results for the fourth quarter and full year 2024 and provided a business update.
CORAL GABLES, Fla., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results